Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-05
1997-06-03
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514395, 514397, 5483044, 5483064, 5483094, 5483097, A61K 31495, A61K 31435, C07D47104, C07D47300
Patent
active
056355254
ABSTRACT:
A compound of the formula ##STR1## in which the symbols have the following meaning: X is a monocyclic radical having 3, 4 or 5 ring atoms,
REFERENCES:
patent: 4728741 (1988-03-01), Kaiser et al.
patent: 5298518 (1994-03-01), Miyake et al.
patent: 5314880 (1994-05-01), Whittaker et al.
patent: 5376666 (1994-12-01), Duncia
patent: 5395840 (1995-03-01), Muller et al.
patent: 5395844 (1995-03-01), Duncia et al.
Gerhards Hermann
Heitsch Holger
Kleemann Heinz-Werner
Scholkens Bernward
Wagner Adalbert
Higel Floyd D.
Hoechst Aktiengesellschaft
LandOfFree
Benzimidazole derivatives as angiotensin II receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole derivatives as angiotensin II receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivatives as angiotensin II receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-392012